+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Omega Ingredients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 100 Pages
  • August 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6266459
The omega ingredients market size was valued at USD 3.83 billion in 2025 and estimated to grow from USD 4.12 billion in 2026 to reach USD 5.95 billion by 2031, at a CAGR of 7.62% during the forecast period (2026-2031). This report is Segmented by Source (Marine, Algae, and Plants), by Product Type (Omega-3 and Omega-6 and Omega-9), by Application (Food and Beverages, Dietary Supplements, Pharmaceutical, Infant Formula, and Animal Nutrition) and by Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Omega Ingredients Market Trends and Insights

Increased Awareness of Omega-3's role in Heart, Brain, and Eye Health

Health-conscious consumers are increasingly incorporating omega-3s into mainstream food applications, moving beyond traditional supplements. The FDA's recent update in December 2024 on "healthy" claim criteria has further accelerated this trend, allowing foods with higher healthy fat content while limiting saturated fats. This regulatory change creates significant opportunities for omega-3 fortified products to qualify for the coveted "healthy" label, enhancing their market positioning and appeal to health-conscious consumers. Clinical evidence continues to grow, highlighting omega-3's neuroprotective benefits, as aging populations actively seek solutions to support cognitive health and overall well-being. Research from institutions like Niigata University demonstrates the potential of engineered yeast to produce EPA with an impressive 85% lipid content, suggesting that advancements in bioavailability will further amplify the effectiveness of health messaging and consumer adoption. Regulatory backing and scientific validation are working in tandem, driving health awareness to translate into market premiums and shifting omega-3 products away from commodity pricing into higher-value segments. Meanwhile, plant-based beverage fortification addresses both health and sustainability concerns. This approach aligns with the preferences of environmentally conscious consumers and captures the growing flexitarian demographic, which seeks versatile and nutritious dietary options.

Sustainability Concerns Driving Plant-Based Preference

The increasing focus on sustainability is significantly driving the demand for plant-based alternatives in the global omega ingredients market. Consumers are becoming more aware of the environmental impact associated with traditional omega ingredient sources, such as fish oil, which often involve overfishing, habitat destruction, and high carbon emissions during production and transportation. This awareness has led to a growing preference for plant-based omega ingredients, which are perceived as more environmentally friendly and sustainable. Additionally, plant-based options, such as those derived from algae, flaxseed, chia seeds, and hemp, offer a viable alternative without compromising on nutritional benefits, including essential fatty acids like omega-3 and omega-6. The shift towards plant-based omega ingredients aligns with broader consumer trends favoring eco-conscious and ethically sourced products, further propelling market growth. Governments and regulatory bodies worldwide are also promoting sustainable practices, which indirectly support the adoption of plant-based omega ingredients. For instance, initiatives aimed at reducing overfishing and encouraging sustainable aquaculture practices have highlighted the need for alternative sources of omega ingredients. Moreover, advancements in technology and research have enabled the development of high-quality plant-based omega ingredients that can match or even surpass the efficacy of traditional sources. These innovations have made plant-based options more accessible and appealing to a wider consumer base, including vegetarians, vegans, and individuals with dietary restrictions.

Challenges in Product Stability and Shelf-Life Management

Product stability and shelf-life management remain significant restraints in the global omega ingredients market. Ensuring the stability of omega ingredients, particularly omega-3 and omega-6 fatty acids, is challenging due to their susceptibility to oxidation, which can lead to reduced efficacy and shorter shelf life. According to the Food and Agriculture Organization (FAO), improper storage conditions and exposure to light, heat, and oxygen are primary factors contributing to the degradation of omega ingredients. Additionally, the Global Organization for EPA and DHA Omega-3s (GOED) highlights that maintaining the quality of omega ingredients during transportation and storage is a critical concern for manufacturers. The United States Food and Drug Administration (FDA) has also emphasized the importance of adhering to Good Manufacturing Practices to mitigate stability issues. Furthermore, the European Food Safety Authority (EFSA) has issued guidelines on the safe handling and storage of omega ingredients to preserve their nutritional value. These challenges necessitate advanced packaging solutions, such as oxygen-impermeable materials and nitrogen flushing, as well as innovative stabilization techniques like microencapsulation. However, implementing these measures can significantly increase production costs, thereby impacting the overall growth of the omega ingredients market.

Other drivers and restraints analyzed in the detailed report include:

  • Growing Demand for Omega Ingredients in Functional Foods and Beverages
  • Advanced Technologies Enhance Extraction and Processing Efficiency
  • Limited Consumer Awareness in Emerging Economies

Segment Analysis

In 2025, marine ingredients held a dominant 45.10% share of the Omega ingredients market, bolstered by established infrastructures in Norway and Peru. Marine ingredients, derived primarily from fish oils and other aquatic sources, have long been the cornerstone of the Omega ingredients market due to their high concentration of essential fatty acids like EPA and DHA. These ingredients are widely used in dietary supplements, functional foods, and pharmaceuticals, driving their sustained demand. Additionally, the abundance of raw materials in regions like Norway and Peru, coupled with well-established supply chains, has ensured a steady production flow. Marine ingredients also benefit from ongoing innovations in extraction and purification technologies, which enhance the quality and bioavailability of Omega fatty acids.

Meanwhile, algae-based sources are making waves, expanding at a robust 11.33% CAGR, a trend set to reshape supply-security dynamics through 2031. Algae-based Omega ingredients are gaining traction as a sustainable and vegetarian alternative to marine sources. They are particularly appealing to consumers seeking plant-based options and to industries aiming to reduce dependency on marine ecosystems. This growth is further supported by advancements in algae cultivation technologies and increasing investments in research and development, which are enhancing production efficiency and cost-effectiveness. The evolving landscape of the Omega ingredients market highlights a shift toward diversification of sources, driven by consumer preferences, sustainability concerns, and supply chain considerations.

Complete Report Scope:

  • By Source
    • Marine
      • Fish
      • Krill
    • Algae
    • Plants
  • By Product Type
    • Omega-3
      • Eicosapentaenoic Acid (EPA)
      • Docosahexaenoic Acid (DHA)
      • Blends
    • Omega-6 and Omega 9
  • By Application
    • Food and Beverages
    • Infant Formula
    • Dietary Supplements
    • Pharmaceuticals
    • Animal Nutrition
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • United Kingdom
      • Germany
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East and Africa
      • Saudi Arabia
      • South Africa
      • Rest of Middle East and Africa

Geography Analysis

The Asia-Pacific region dominates the global omega ingredients market in 2025, holding a substantial 48.20% market share. It is also projected to achieve the fastest regional growth, with a robust CAGR of 12.78% through 2031. This growth is primarily driven by China's efforts to modernize its regulatory framework, which facilitates the adoption of omega-3 products. Additionally, India's rapidly expanding supplement market is contributing significantly to the region's growth, as consumer awareness regarding health and wellness continues to rise. Japan further strengthens the region's position with its technological advancements in omega-3 production, particularly in refining and innovating production processes to meet global demand efficiently.

North America remains a key player in the omega ingredients market, supported by well-established supplement consumption patterns and regulatory frameworks that endorse omega-3 health claims. These factors have helped the region maintain a significant market presence. However, the region faces challenges in its supply chain as traditional marine sources of omega-3 encounter sustainability constraints. This has prompted a shift toward alternative sources, such as algae-based omega-3, which are gaining traction due to their environmental benefits and growing consumer preference for sustainable products. The region's ability to adapt to these changes will be critical in sustaining its market position.

Europe continues to lead in regulatory advancements, setting global standards for omega-3 production. The European Union's mandatory DHA requirements in infant formulas and the establishment of precision fermentation guidelines highlight the region's commitment to quality and safety. The European Food Safety Authority (EFSA) has further reinforced this leadership by approving multiple Schizochytrium strains for use in infant formula applications, showcasing confidence in the safety and efficacy of algae-based omega-3. Meanwhile, emerging markets in the Middle East and Africa and South America are showing promising growth potential. Economic development in these regions is driving increased healthcare spending and greater awareness of nutrition. However, fragmented regulatory frameworks pose challenges, necessitating localized market entry strategies to effectively tap into these opportunities.

List of Companies Covered in this Report:

  • DSM-Firmenich AG
  • BASF SE
  • Archer Daniels Midland Company
  • Cargill, Incorporated
  • Corbion N.V.
  • KD Pharma Group
  • NU-MEGA Ingredients Pvt.Ltd.
  • Polaris Inc.
  • Aker BioMarine ASA
  • GC Rieber VivoMega
  • Golden Omega SA
  • Croda International Plc
  • Pelagia AS
  • Veramaris V.O.F.
  • Solutex GC SL
  • Fermentalg SA
  • Algaecytes Ltd
  • Cellana Inc.
  • Neptune Wellness Solutions
  • Nordic Naturals Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Awareness of Omega-3's role in Heart, Brain, and Eye Health
4.2.2 Sustaniability Concerns Driving Plant-Based Preference
4.2.3 Growing Demand for Omega Ingredients in Functional Foods and Beverages
4.2.4 Advanced Technologies Enhance Extraction and Processing Efficiency
4.2.5 Rising Demand in Infant Nutrion Propelling the Market Growth
4.2.6 Technological Advancements in Production
4.3 Market Restraints
4.3.1 Limited Consumer Awareness in Emerging Economies
4.3.2 Challenges in Product Stability and Shelf-Life Management
4.3.3 Supply Chain and Raw Material Constraints
4.3.4 Lack of Standardized Recommened Daily Intake
4.4 Supply Chain Analysis
4.5 Regulatory Outlook
4.6 Porter's Five Forces
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
5 MARKET SIZE AND GROWTH FORCASTS (VALUE)
5.1 By Source
5.1.1 Marine
5.1.1.1 Fish
5.1.1.2 Krill
5.1.2 Algae
5.1.3 Plants
5.2 By Product Type
5.2.1 Omega-3
5.2.1.1 Eicosapentaenoic Acid (EPA)
5.2.1.2 Docosahexaenoic Acid (DHA)
5.2.1.3 Blends
5.2.2 Omega-6 and Omega 9
5.3 By Application
5.3.1 Food and Beverages
5.3.2 Infant Formula
5.3.3 Dietary Supplements
5.3.4 Pharmaceuticals
5.3.5 Animal Nutrition
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 Germany
5.4.2.3 Spain
5.4.2.4 France
5.4.2.5 Italy
5.4.2.6 Russia
5.4.2.7 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 India
5.4.3.3 Japan
5.4.3.4 Australia
5.4.3.5 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 Saudi Arabia
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Company Ranking Analysis
6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.4.1 DSM-Firmenich AG
6.4.2 BASF SE
6.4.3 Archer Daniels Midland Company
6.4.4 Cargill, Incorporated
6.4.5 Corbion N.V.
6.4.6 KD Pharma Group
6.4.7 NU-MEGA Ingredients Pvt.Ltd.
6.4.8 Polaris Inc.
6.4.9 Aker BioMarine ASA
6.4.10 GC Rieber VivoMega
6.4.11 Golden Omega SA
6.4.12 Croda International Plc
6.4.13 Pelagia AS
6.4.14 Veramaris V.O.F.
6.4.15 Solutex GC SL
6.4.16 Fermentalg SA
6.4.17 Algaecytes Ltd
6.4.18 Cellana Inc.
6.4.19 Neptune Wellness Solutions
6.4.20 Nordic Naturals Inc.
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DSM-Firmenich AG
  • BASF SE
  • Archer Daniels Midland Company
  • Cargill, Incorporated
  • Corbion N.V.
  • KD Pharma Group
  • NU-MEGA Ingredients Pvt.Ltd.
  • Polaris Inc.
  • Aker BioMarine ASA
  • GC Rieber VivoMega
  • Golden Omega SA
  • Croda International Plc
  • Pelagia AS
  • Veramaris V.O.F.
  • Solutex GC SL
  • Fermentalg SA
  • Algaecytes Ltd
  • Cellana Inc.
  • Neptune Wellness Solutions
  • Nordic Naturals Inc.